Important Vinpocetine safety notice
Vinpocetine is one of the 19 named compounds in Neurapezil's proprietary blend. The FDA has issued safety communications regarding potential reproductive risks associated with Vinpocetine. Consumers who are pregnant, may become pregnant, or are nursing should avoid products containing Vinpocetine unless directed otherwise by a licensed healthcare provider.
Who should be cautious
- Pregnant or nursing individuals: Avoid due to the Vinpocetine content, unless directed otherwise by a doctor.
- Epilepsy: Consult a healthcare provider before use, per the label's caution language.
- Diabetes, high blood pressure, or kidney disease: Consult a healthcare provider before use.
- Under 18: Not recommended for individuals under 18.
- Prescription medications: Review the full ingredient list with your physician before starting.
Not a substitute for prescribed treatment
Neurapezil is not intended to diagnose, treat, cure, or prevent any disease, and it does not replace medical care or prescribed treatment for Alzheimer's disease, dementia, epilepsy, or any diagnosed condition.
When to stop and see a doctor
Discontinue use and consult a physician if you experience any unusual or concerning symptoms after starting Neurapezil. This article is general information, not medical advice — see our full disclaimer for details.
Bottom line
For healthy adults without the conditions above, Neurapezil's ingredient profile carries a generally reasonable safety profile — but the Vinpocetine content makes it especially important for pregnant or nursing individuals, and anyone managing epilepsy, diabetes, high blood pressure, or kidney disease, to talk to their doctor first.